Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 5/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1400797 | 1.00 | PDK2 (0.32) | PDK2HTR2CSLC6A4HTR2AKDM4E | |
| SCHEMBL5198621 | 0.88 | KDM4E (0.43) | KDM4EAKR1C3PPARD | |
| SCHEMBL4607036 | 0.85 | GLS (0.37) | HTR2CSLC6A4KDM4EAKR1C3 | |
| SCHEMBL4607033 | 0.85 | GLS (0.37) | HTR2CSLC6A4KDM4EAKR1C3 | |
| SCHEMBL68768 | 0.83 | KDM4E (0.34) | KDM4EAKR1C3 | |
| SCHEMBL68767 | 0.83 | KDM4E (0.34) | KDM4EAKR1C3 | |
| SCHEMBL5198183 | 0.81 | RXRA (0.41) | PPARD | |
| SCHEMBL1400847 | 0.80 | PTGER1 (0.34) | PDK2HTR2CSLC6A4HTR2APPARD | |
| SCHEMBL1400849 | 0.80 | PPARG (0.37) | PDK2HTR2CSLC6A4PPARDPTGES | |
| SCHEMBL4968634 | 0.74 | AKR1C3 (0.49) | KDM4EAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1814871-B1 | COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | GALDERMA RES & DEV (FR) | 2011-03-02 | — | — | EP | disclosed |